Cabergoline as treatment of ovarian hyperstimulation syndrome: a review.
Gynecol Endocrinol
; 29(2): 98-100, 2013 Feb.
Article
em En
| MEDLINE
| ID: mdl-23110560
ABSTRACT
One of the most serious complications of assisted reproduction techniques is ovarian hyperstimulation syndrome (OHSS). OHSS not only increases morbidity and mortality in IFV cycles, but also causes significant other problems, as cancelled in vitro fertilization (IVF) cycles, prolonged hospitalization, causing emotional and sociofinancial consequences. Several treatments for OHSS have been proposed and among these Cabergoline (Cb2). Despite the above-mentioned beneficial effect, Cb2 has not been widely used in everyday's clinical practice. With our study, we try to review all studies with strong evidence examining Cb2 use for OHSS prevention.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Ovário
/
Síndrome de Hiperestimulação Ovariana
/
Agonistas de Dopamina
/
Ergolinas
Limite:
Female
/
Humans
Idioma:
En
Ano de publicação:
2013
Tipo de documento:
Article